|
1
|
Yuan Z, Peng L, Radhakrishnan R and Seto
E: Histone deacetylase 9 (HDAC9) regulates the functions of the
ATDC (TRIM29) protein. J Biol Chem. 285:39329–39338. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Clocchiatti A, Florean C and Brancolini C:
Class IIa HDACs: From important roles in differentiation to
possible implications in tumourigenesis. J Cell Mol Med.
15:1833–1846. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kotian S, Liyanarachchi S, Zelent A and
Parvin JD: Histone deacetylases 9 and 10 are required for
homologous recombination. J Biol Chem. 286:7722–7726. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lai IL, Lin TP, Yao YL, Lin CY, Hsieh MJ
and Yang WM: Histone deacetylase 10 relieves repression on the
melanogenic program by maintaining the deacetylation status of
repressors. J Biol Chem. 285:7187–7196. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Oehme I, Lodrini M, Brady NR and Witt O:
Histone deacetylase 10-promoted autophagy as a druggable point of
interference to improve the treatment response of advanced
neuroblastomas. Autophagy. 9:2163–2165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oehme I, Linke JP, Böck BC, Milde T,
Lodrini M, Hartenstein B, Wiegand I, Eckert C, Roth W, Kool M, et
al: Histone deacetylase 10 promotes autophagy-mediated cell
survival. Proc Natl Acad Sci USA. 110:E2592–E2601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pinto G, Shtaif B, Phillip M and
Gat-Yablonski G: Growth attenuation is associated with histone
deacetylase 10-induced autophagy in the liver. J Nutr Biochem.
27:171–180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Peng L and Seto E: Histone
deacetylase 10 regulates the cell cycle G2/M phase transition via a
novel let-7-HMGA2-cyclin A2 pathway. Mol Cell Biol. 35:3547–3565.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Radhakrishnan R, Li Y, Xiang S, Yuan F,
Yuan Z, Telles E, Fang J, Coppola D, Shibata D, Lane WS, et al:
Histone deacetylase 10 regulates DNA mismatch repair and may
involve the deacetylation of MutS homolog 2. J Biol Chem.
290:22795–22804. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Osada H, Tatematsu Y, Saito H, Yatabe Y,
Mitsudomi T and Takahashi T: Reduced expression of class II histone
deacetylase genes is associated with poor prognosis in lung cancer
patients. Int J Cancer. 112:26–32. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park BL, Kim YJ, Cheong HS, Lee SO, Han
CS, Yoon JH, Park JH, Chang HS, Park CS, Lee HS and Shin HD: HDAC10
promoter polymorphism associated with development of HCC among
chronic HBV patients. Biochem Biophys Res Commun. 363:776–781.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee JH, Jeong EG, Choi MC, Kim SH, Park
JH, Song SH, Park J, Bang YJ and Kim TY: Inhibition of histone
deacetylase 10 induces thioredoxin-interacting protein and causes
accumulation of reactive oxygen species in SNU-620 human gastric
cancer cells. Mol Cells. 30:107–112. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan W, Huang J and Xiao H: Histone
deacetylase 10 suppresses proliferation and invasion by inhibiting
the phosphorylation of β-catenin and serves as an independent
prognostic factor for human clear cell renal cell carcinoma. Int J
Clin Exp Med. 8:3734–3742. 2015.PubMed/NCBI
|
|
14
|
Powers J, Lienlaf M, Perez-Villarroel P,
Deng S, Knox T, Villagra A and Sahakian E: Expression and function
of histone deacetylase 10 (HDAC10) in B cell malignancies. Methods
Mol Biol. 1436:129–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang Y, Huang Y, Wang Z, Wang HT, Duan B,
Ye D, Wang C, Jing R, Leng Y, Xi J, et al: HDAC10 promotes lung
cancer proliferation via AKT phosphorylation. Oncotarget.
7:59388–59401. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Islam MM, Banerjee T, Packard CZ, Kotian
S, Selvendiran K, Cohn DE and Parvin JD: HDAC10 as a potential
therapeutic target in ovarian cancer. Gynecol Oncol. 144:613–620.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang X, Liu J, Zhen J, Zhang C, Wan Q, Liu
G, Wei X, Zhang Y, Wang Z, Han H, et al: Histone deacetylase 4
selectively contributes to podocyte injury in diabetic nephropathy.
Kidney Int. 86:712–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song C, Zhu S, Wu C and Kang J: Histone
deacetylase (HDAC) 10 suppresses cervical cancer metastasis through
inhibition of matrix metalloproteinase (MMP) 2 and 9 expression. J
Biol Chem. 288:28021–28033. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jin Z, Jiang W, Jiao F, Guo Z, Hu H and
Wang L and Wang L: Decreased expression of histone deacetylase 10
predicts poor prognosis of gastric cancer patients. Int J Clin Exp
Pathol. 7:5872–5879. 2014.PubMed/NCBI
|
|
21
|
Petrelli F, Tomasello G, Borgonovo K,
Ghidini M, Turati L, Dallera P, Passalacqua R, Sgroi G and Barni S:
Prognostic survival associated with left-sided vs right-sided colon
cancer: A systematic review and meta-analysis. JAMA Oncol. Oct
27–2016.(Epub ahead of print).
|
|
22
|
Bauer KM, Hummon AB and Buechler S:
Right-side and left-side colon cancer follow different pathways to
relapse. Mol Carcinog. 51:411–421. 2012. View Article : Google Scholar : PubMed/NCBI
|
